GlassScriptPhysician profile
Meghan A Patel
NPI 1801027073
$630.37
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $415 · 2020: $78.02 · 2021: $45.92 · 2022: $35.60 · 2023: $13.01 · 2024: $42.56.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $55.57.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $55.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $197.90 | 2019 | |
| Abbvie INC. | $89.35 | 2019-2022 | |
| Intuitive Surgical, INC. | $49.17 | 2019 | |
| Hologic Sales and Service, LLC | $36.05 | 2019-2024 | Aptima |
| Amgen INC. | $35.51 | 2019-2020 | |
| Astellas Pharma US INC | $34.28 | 2020-2021 | |
| Evofem Biosciences, INC. | $33.43 | 2021 | |
| Amag Pharmaceuticals, INC. | $29.99 | 2019-2020 | |
| Allergan, INC. | $29.38 | 2019 | |
| Acera Surgical, INC. | $25.95 | 2024 | Restrata Wound Matrix |
| Coopersurgical, INC. | $17.50 | 2019 | |
| Millicent US INC | $15.74 | 2020 | |
| Pfizer INC. | $13.01 | 2023 | |
| Duchesnay USA Incorporated | $12.14 | 2019 | |
| Avion Pharmaceuticals | $10.97 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meghan Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.